Top Clinical Trials companies in Netherlands by Operating Income Margin
Netherlands
# |
Name |
Operating Income Margin |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
-34.66%
|
Dec. 31, 2023 | USD 667.09 | 1.81% |
|
Netherlands |
|
| 2 |
-356.22%
|
Dec. 31, 2023 | USD 40.94 | -1.52% |
|
Netherlands |
|
| 3 |
-489.09%
|
Dec. 31, 2023 | USD 2.12 | -1.40% |
|
Netherlands |
|
| 4 |
-638.99%
|
Dec. 31, 2023 | USD 0.98 | -1.01% |
|
Netherlands |
|
| 5 |
-1,298.56%
|
Dec. 31, 2023 | USD 22.29 | 2.39% |
|
Netherlands |
|
| 6 |
-1,785.46%
|
Dec. 31, 2023 | USD 15.74 | -0.32% |
|
Netherlands |
Frequently Asked Questions
-
Which Clinical Trials company in Netherlands has the highest Operating Income Margin ?
The Clinical Trials company in Netherlands with the highest Operating Income Margin is argenx SE (Brussels Stock Exchange: ARGX.BR) at -34.66%.
-
Which Clinical Trials company in Netherlands has the lowest Operating Income Margin ?
The Clinical Trials company in Netherlands with the lowest Operating Income Margin is uniQure N.V. (NasdaqGS: QURE) at -1,785.46%.
-
What are the top 10 Clinical Trials companies in Netherlands by Operating Income Margin ?
The top 10 Clinical Trials companies in Netherlands by Operating Income Margin are argenx SE, Merus N.V., ProQR Therapeutics N.V., LAVA Therapeutics N.V., NewAmsterdam Pharma Company N.V. and uniQure N.V..
-
What are the bottom 10 Clinical Trials companies in Netherlands by Operating Income Margin ?
The bottom 10 Clinical Trials companies in Netherlands by Operating Income Margin are uniQure N.V., NewAmsterdam Pharma Company N.V., LAVA Therapeutics N.V., ProQR Therapeutics N.V., Merus N.V. and argenx SE.
